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Statistical Evaluation of Mutagenicity
Test Data: Recommendations of the U.K.
Environmental Mutagen Society
by David J. Kirkland
Mostofthemanypublishedguidelinesonhowtoconductmutagenicitytestsdonotgiveadviceorreferencesonstatistical
analysis ofdata. TheU.K. Environmental MutagenSociety decided toaddressthisomission, andin 1985established 8
workinggroupscomprisinggenetictoxicologistsfromall sectorsofthescience, plusatleast2statisticianspergroup, to
produce statistics guidelineson 10different testsystems. Eachgroupgaveadviceonhowtodeterminethesuitabilityof
datafordistribution fitting, when dataareunsuitable, whenandhowdatashouldbetransformed, whichstatistical tests
aresuitableforagivensetofdata, whichfacorsgovernthechoiceofstatisticaltest,anorderofpreference, andsomeworked
examplesusingrealdata. Inaddition, groupsgaveadviceonstatisticalissuesinthedesignofexperiments. Strongrecom-
mendationsweremadethatforin Totests,sufficientcellsbetreatedandsampledtoprovidemeaningfulvaluesofspon-
taneousmutant/aberrationfrequencies, forgenuine, independentreplicatetentstobeused,andthattheacceptability
Ofanexperimentshouldbebasedonhomogeneitybetweenreplicatesaswellascomparisonofnegativeandpositivecontrol
responses withhistorical ranges. It wasrecommended that mostin Wm studiesshouldinclude independent repeat ex-
periments, andadvicewasgivenonhowtocheckforconsistencybetweenexperimentsandthencombinedataforfurther
significancetesting. Forinvvotests,itwasgenerally believedthatincreasingthenumberofdoselevelsandreducingthe
numberofanimals perdoseimposes statistical sensitivity; there wassomeuncertainty about howtohandledatawhen
heterogeneity wasfoundwithinagroupofanimals, buttherewasaconsensusthatstatistical testsandinterpretationof
thebiological findings should proceed.
Introduction
Many guidelines formutagenicity testing [e.g., Organisation
for Economic Cooperation and Development (1-3). European
Economic Community (EEC) (4), and U.K. Environmental
Mutagen Society (UKEMS) (5,6)] that have made recommenda-
tions on methods for generation ofdata have not made similar
recommendations onanalysisofdata. Statements such as "data
should be analysed using appropriate statistical methods" are
common, withoutreferring thereaderto anyusefulpublication.
Interestingly, it appears the Japanese Ministry of Health and
Welfarehas notrequestedintheirguideline(7)thatmutagenicity
data be analysed statistically. UKEMS decided that, having
published twoguidelinebooks onhow to generatedata(5,6), it
shouldattempttoprepareasimilarguidelineonstatisticalanaly-
sis ofdata.
Organization
Asinthepast, UKEMSdecidedrecommendations shouldbe
achievedby consensus, rather thanbeingthoseofanindividual,
and for each topic a working group consisting offive to nine
members was convened. Each group was chaired by a genetic
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toxicologist with recognized experience in the topic area, and
each group included at least two statisticians. Working group
members were selected to represent all sectors ofthe science,
namely, academic, industrial, and contract laboratory genetic
toxicologists and statisticians. A steering group (effectively a
subcommitteeofUKEMS) wasestablishedtooverseetheexer-
cise, andcomprised sevengenetictoxicologists andthreestatisti-
ciansrepresentingthesamescientificsectorsasabove, butalso
including representatives ofU.K. regulatory authorities.
Aims and objectives
Ten different mutagenicity test systems were selected for
assessment and grouped into eight topics. For each topic, the
workinggroupwasrequiredtoconsider: a)howtodeterminethe
suitabilityofdataobtainedfromanassayforfittingadistribution,
when the data are unsuitable, when and how data should be
transformed; b)thetypesofstatisticalanalysesthatcanbeused
with theassay dataunderconsideration, which, ifany, factors
govern the choiceofanalysis, anorderofpreference ifseveral
typesofanalysismaybeused; andc) someexamplesusingreal
datatohelpthereaderunderstandtheabove. Inaddition, working
groupswereaskedtoconsiderthestatisticalimplicationsofex-
perimental design, and to make recommendations where
appropriate.
Finally, withtheexceptionofgeneralprinciplesthatwouldbe
presented in an introductory chapter, and could be referred to
in any ofthe individual reports, each report was to be writtenRECOMMENDAT7ONSFOR STATISTICS WI7HMUTAGENICITYDATA
to stand alone. The reason for this dates back to the original
UKEMS reports, whichwereratherlikehandbooks, andanex-
perimenterinterested inonetopicwouldfindalltherelevantin-
formation inasinglechapter. It wasrecognizedthatthisapproach
withastatisticsbookcouldleadtosomerepetitionorevensome
contradictions. UKEMS was prepared to accept repetition in
returnforthebenefitsofprovidingintegralchapters. Contradic-
tionswouldbeavoidedbyfollowingapreviouslyestablishedpro-
cedure, namely, a)workinggroupsdiscussobjectives, chairman
(or statistician) drafts manuscript, othergroup members com-
ment; b) corrected manuscript reviewed by steering group
members individually, commentscollatedononecopy, returned
to working group chairman; c) steering group andall working
group chairmen meet to see if all comments can be accom-
modated, particularly aiming to remove inconsistencies between
different manuscripts.
Recommendations
Alloftheworkinggroupsassociatedwithin vitromutagenicity
techniques made strong recommendations for treating and
sampling sufficientcellstoprovidemeaningfulvaluesforspon-
taneous mutant/aberration frequencies. All recommended the
use ofgenuinely independent replicate treatments in all cases
(minimumofthreeforbacterialcolonyassays, mimimumoftwo
forallotherin vitroassays). Theyalsorecommendedthatjudg-
ment ofthe acceptability ofan experiment shouldbe based on
twofactors: comparisonofnegativeandpositivecontrolvalues
with some appropriate historical range, and a measure of
heterogeneity/dispersion between replicate cultures. Forall in
vitrotestsexceptchromosomal aberration, strong recommenda-
tionsweremadeforexperiments toberepeatedatleastonce. In
many cases, advice was given on how tocheck forconsistency
between experiments, how to combine data from separate but
consistentexperiments, andhowtoperformfurthersignificance
tests. Ifconsistency was not obtained, additional experiments
were recommended.
Theworkinggroupsconcernedwithin vivotestsinmammals
also made some recommendations regarding study design. In
general itwasfeltthatincreasingthenumberofdosesandreduc-
ingthenumberofanimalsperdoseimprovedthestatistical sen-
sitivity, butchecksforheterogeneitybetweenanimalsshouldbe
made. Other specific recommendations oftheworking groups
are summarized below.
Microbial Colony Assays (AmesTest)
Inthemostwidelyusedassays, 107-108SalmonellaorE. coli
bacteria with a nutritional mutation are treated with test
chemical, with and without exogenous metabolism, plated in
agarwith atrace amountoftherequired aminoacid, andincu-
batedfor2-3days. Onlybacteriathathavefullyrevertedtoinde-
pendence can grow after the trace of amino acid has been
exhausted, and they produce discrete colonies. Spontaneous
mutation rates lead to 5-200 colonies/plate (depending on
strains), andincreases innumbers ofcolonies areindicativeof
a mutagenic effect. Some authors have reported Ames colony
counts to be distributed according to Poisson statistics (8) and
othershavereportedthemtobemorevariablethanwouldbeex-
pected from the Poisson (9,10). Our authors therefore recom-
mendedsamplevariationbefirstdeterminedbydividingthex2
value for the data set by its degrees of freedom to give the m
statistic. Ifthe m-statistic is <1, then significance tests which
assumethe Pbissondistribution can be used.
Ifmliesbetween 1 and, say, twicetheaveragehistoricalvalue
inthelaboratory, thenamethodallowingvariationgreaterthan
Poisson, should be used. If m exceeds twice the laboratory
average, thenthe experiment should be discarded.
AsAmestestdataareoftennotPbisson, statisticalsignificance
methods based on observed variance are perhaps the most
logical. Oftheparametricmethodsthatallowformultiplecom-
parisons, Dunnett'st-test(11,12) ispreferred. Variousregression
methods were recommended forlooking atdose response, the
typeofregressiondepending onthechoiceoftransformationor
weighting, andwhetheranydownturnintheresponsecurveisex-
cluded or modeled. Of the nonparametric methods, Wahren-
dorfs ranking method (13) was preferred.
Computersimulationswereusedtocomparethesensitivityof
these three methods, using untransformed data and data
transformed by various methods. The following conclusions
werereached: a)untransformeddatayieldedmoresignificantef-
fects than data transformed by square root, inverse hyperbolic
sine, or log transformations; b) linearregressionand Wahren-
dorf's method were more powerful than Dunnett's test, par-
ticularlywhencolonycountsweresmallandhighlyvariable; c)
toxicity-inducedreductionincolonycountsathighdosesaffected
thepowerQflinearregressionandWahrendorfs methods much
more than itaffected Dunnett's test.
Mammalian Cell Gene Mutation Colony Assays
Ingenemutationcolonytests, cellsthatarenormallysensitive
to apoison are examined for resistance to its toxic effects after
treatment. Coloniesmaybeselectedinagar(similartotheAmes
test)orinliquidmedium, inwhichcasetheygrowasdiscretecol-
onies on a plastic surface and are usually stained to visualize
them. Spontaneousmutantfrequenciesdependonthecell type
and genetic locus examined, but are generally higher than in
Ames bacteria and range from 4 x 1i-7 to 1 x 10-4. To avoid
zero mutantcounts on control ortreatedplates, large numbers
ofcellsmustbeplated, andtechnicalrestrictions canmakethis
impractical for some systems. The working group therefore
recommended suspension ratherthanmonolayercultures, and
geneticlociwithhighspontaneousmutantfrequencies. Thus, 7K
mutation in mouse lymphoma cells becomes the method of
choice on statistical grounds.
Even with this system, the assays are so large that there are
usuallyinsufficientgenuinelyindependentreplicateobservations
topermittheuseofnonparametricmethods. Ofthemorepower-
fulparametricmethods, theauthorspreferredweightedregres-
sion to transformation ofthe data because it allows a test for a
directrelationshipbetweenmutantfrequencyanddose. Various
formsofweightingmaybeused,butPbisson-derivedweightsare
simplertocalculate, andmaygivemorerealisticweightingwhen
plateshavebeenlost; andtherewasnofirmevidencetosuggest
thecounts were not Poissondistributed.
Thegrouprecommendedthefirststageofanalysisshouldbe
analysisofvarianceonweightedmutantfrequenciestodetermine
if differences between groups were greater than between
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replicates. The second stage should then be a t-test to examine
significance at a test dosecompared with control. The recom-
mendedprocedure usesestimatesofbetween-replicatesresidual
error mean square and weights to obtain estimates ofvariance
and standard error ofmean mutant frequency at each dose.
Finally, doseresponsecouldbeexaminedbyperformingatest
forlineartrendwithintheanalysisofvariancetable, theslopeof
the straight line being
cross product (mutant frequency x dose).
doses sum ofsquares
Bacterial/Mammalian Cell Fluctuation Tests
Bacterial andmammalian cell fluctuation tests are similar in
principle tothecolony testsdiscussedabove, exceptthe selection
ofmutantsdoesnottakeplaceinagaroronlargeplasticdishes,
butthepopulationofcells/bacteriaisdividedupintomanysmall
wells, and numbers of empty wells are counted instead of
colonies.
Ifonelooks atreplicate96-wellplatesfromthesameculture,
thentheproportion ofempty wells variesbinomially. However,
extravariability isfoundwhenoneobservesplates fromdifferent
cultures, particularly after prolonged subculturing (14). The
authors compared observed variances from several experiments
withtheoreticalbinomialvariancesandfoundtheratiotobefair-
ly constant. The groups believed this was a good measure,
therefore, ofvariability withinanexperimentanddecidedtocall
the ratio the heterogeneity factor after its comparable use in
biological assays(15). Althoughtheratiocanbeestimatedfrom
a singleexperiment, the authors recommended each new ratio
fromanewexperimentbeusedtoupdate(say, intheproportions
of 19:1) ahistorical valueandthenbecompared withit. Accor-
ding to theF-distribution, heterogenicity factors exceeding the
updatedhistorical valuemorethan 10.8-foldwouldbeextreme-
ly rare(0.1% one-sided, with 1 andinfinitedegreesoffreedom),
and cultures with such values should beexcluded.
Formammaliancelltests, analysisusingtwotypesofstatistical
testwas recommended, firsttocomparetheweighted-meanlog
mutantfrequencyfromeachtreatmentwithcontrol, andsecond
tocheckforlineartrendbyweightedregression. Bothmethods
usetheheterogeneity factordescribedabovetoobtainamodified
estimate ofvariance.
Forbacterial tests, thereiscontinuousincubationwiththetest
compoundandnosubculturing tointroduceadditional erroras
inthemammalian cellversion. Variationbetweenreplicatetrays
appears tobebinomiallydistributed, andthereforedirectcom-
parisons betweentreatedandcontrolculturesusing2 x 2tables
canbemade. Valuesofx2 canthenbecomparedwithDunnett's
valuesformultiplecomparisons. There is no separate measure
ofviability aftertreatment inthebacterial fluctuation test, and
so dose response should be assessed using a test for isotonic
trend, whichismuchmorerobustinthepresenceoftoxicity(16).
In Vitro Cytogenetic Assays
Cytogenetic tests examine induction ofgross chromosomal
damage in metaphase preparations ofrodent or humancells at
appropriatetimes after treatment. After muchdiscussion, and
perhaps controversy, the authors decided the cell, and not the
chromosome, was theexperimental unit.
Theythusrecommendedthedatabeclassified intotwobasic
groups: normaloraberrantcells. Asthebiologicalconsequences
ofsmalldiscontinuities (gaps) inthechromosomeareuncertain,
theaberrantcellsareusuallyclassifiedasincludingorexcluding
gaps, butmostconclusionsaredrawnonproportionsofaberrant
cells excluding gaps.
In an acceptable assay, it is assumed that the variability be-
tweencellssampledfromdifferentculturesisnogreaterthanthat
between cells sampled from the same culture. It is therefore
recommendedthatacceptablehomogeneitybecheckedusingthe
binomial dispersion test.
Assumingacceptable homogeneity, recommendeddata from
replicatesarecombined, givinganoverallproportionofaberrant
cells foreach treatmentor negative control; theproportions at
each treatment are compared with the control using Fisher's
exact test.
Sister Chromatid Exchange Tests
Sisterchromatidexchanges (SCEs)arereciprocalexchanges
betweenthe sisterchromatidsofachromosome andrepresenta
consequence of genetic damage, which is, as yet, poorly
understood. Theexperimentalunitiseithertheculture(in vitro)
orthe animal (in vivo).
Sisterchromatidexchanges inChinesehamsterovary (CHO)
cellsarePoissondistributed (17),butinhumanlymphocytesand
inanimalstheyarenot; andthereis nosinglefamilyofdistribu-
tions thatcanbe used forall data sets (18). Although a square-
roottransformation canthereforebeused forSCEinCHOcells,
appropriate transformations for other systems need to be em-
pirically determined.
Thetransformationistoensurethatthedatatobeanalyzedare
ofapproximately constantvariance, andthenitis recommended
thatanalysisofvariance (ANOVA) becarriedout. The formof
ANOVAcan,however,bechosenwhendifferencesbetweenrepli-
cateculturesoranimalshavebeenchecked. Between-cellsorbe-
tween-culturesestimateerrorswillthenbechosenasappropriate.
Finally, doseresponsecanbecheckedbyperforming atrend
test of treatment totals, and this can be performed on un-
transformeddatawhenaPoissonmodelissatisfied, asinthecase
ofCHO cells.
Micronucleus TestIn Vivo
Inthisassay, chromosomefragmentsorwholechromosomes
thatdonotsegregatecorrectlybecomedetachedfromthemain
nucleusofbonemarrowcellsand, whenthemainnucleusisex-
pelledtoformanerythrocyte, theyareleftbehindandappearlike
micronuclei. Cellseitherhavemicronuclei ortheydo not, and
the relative rarity of micronucleated cells in control animals
(<4/1000) means theirdistributionapproximates to Poisson.
A whole raft of different significance tests (analysis of
variance, likelihood ratiotests, generalized linearmodels, and
2 x 2contingencytables)haveallproducedsimilarconclusions
withsamplemicronucleusdataandcanbeequallyrecommend-
ed. TheKruskal-Wallis, Mann-Whitney UandJonckheeres non-
parametric tests are all feasible alternatives.
Theauthorsdidrecommend, however, thatat-testshouldnot
beusedwithouttransformationofthedata, andKastenbaumand
Bowman tables should not be used without first checking for
heterogeneity between animals.
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Chromosomal Aberrations In Vivo
Theendpointofthechromosomalaberrationsassay issimilar
tothat in vitro, and it is assumed thatvariationbetween cells in
an animal is binomially distributed. However, variability bet-
weenanimals in vivoisgenerallygreaterthanbetweenreplicate
cultures in vitro.
Ax2 testoranalysis ofvarianceafterarcsintransformation of
thedata is recommended to testsignificance, butthere is some
debate as to whether these tests should be modified if
heterogeneity within groupsofanimals isfound. Acompromise
wassuggested suchthatatestforheterogeneity isperformed, and
the findings reported, butthen x2 tests carried out regardless.
Other Tests
The dominant lethal and Drosophila sex-linked recessive
lethal tests are infrequently used, and will be dealt with only
briefly. Avariety ofapproaches suchasnonparametric, normal
distribution, andf-binomial methodscanbeusedwithdominant
lethal data, butthedesignofthestudies mustincludedeliberate
randomization of animals if any of these approaches is to be
valid.
ForDrosophilaassays, atestbasedonthenormalapproxima-
tiontothebinomial distribution isfavored, unlesssample sizes
are small, andthentheconditional binomial shouldbeused. The
data are not suitable foranalysis by Fisher's exacttest.
Conclusions
Ithasbeenpossibleheretomakeonlyaverycursoryoverview
ofthe lengthy discussions presented in the UKEMS statistical
guidelines (19), but it is hoped that the benefits ofajoint ap-
proachbetweenstatisticians andbiologistswillbecleartoalland
thatitmay promptotherstouseasimilarcollaborativeapproach
in the future.
Appendix
Discussion ofLecture
Q. Someguidelines recommendthreeplates/dosefortheAmes
test and others (e.g., Japan) recommend two. What does
UKEMS recommend?
A . As many bacteria aspossible should beplated. Ithinkthe
workinggroupactually recommendedfourreplicates/dose
as a minimum but knew this was out of line with
OECD/EEC guidelines. What was most important was to
increasethenumberofplatesinnegativecontrolgroupsto
twicethoseintreatedgroups (e.g., 6plates/control) toim-
prove sensitivity.
Q. Arefereeofapaperwasaskingfortransformationofin vivo
SCEdatabecauseheterogeneitybetweenanimals was seen
at the doses producing a positive response. Did UKEMS
recommend all SCEdatabetransformed?
A . No. UKEMS recognized SCE inCHOcells werePoisson
distributed and so could easily be transformed by taking
squareroots. Itwasnotedthatinothercelltypesandinvivo,
SCE were not Poisson distributed. The recommendation
was tolookatthedataandseewhattransformation, ifany,
was appropriate. Furthermore, we would usually exclude
positively responding animals from heterogeneity checks
becauseweexpectgreatervariation inthoseanimals, soIdo
not agree with the referee's logic orconclusion.
Q. WhydidUKEMSnotusethenonparametricrecursiverank-
ing method ofSimpson and Margolin fortheAmes test?
A. Probablybecausetheauthorofthischapterhadworkedwith
Wahrendorf.
Q. Sometimes Ames data from some strains in the negative
control situation, andothertimeswithpositiveresponses,
show non-Poisson distribution. How does this affect
UKEMS recommendation fortests?
A. We recognized that overdispersion occurs on some occa-
sions, particularly wheretherearepositiveresponses, and
sothe simulation study used apositive response with data
distributedaccordingtonegativebinomial. AsImentioned
earlier, untransformed datagavehighersignificancevalues
thantransformeddataand, dependingonwhethertherewas
a downturn through toxicity, you could choose Dunnett's
test, linearregression, orWahrendorfstest. Ithinkwetried
inthebooktoencouragepeopletolookattheirdataandsee
thebestwaytohandleit, notbeingtoorigid. Ithinkwealso
madeoneveryclearstatement: whateverresultthestatistical
analysisgives,the biological conclusion ismostimportant.
Statisticalanalysis isanaidtothatbiological conclusion; it
is nottheconlusion itself.
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